COVID-19 and financial toxicity in patients with renal cell carcinoma.
Michael D StaehlerDena J BattleCristiane D BergerotSumanta Kumar PalDavid F PensonPublished in: World journal of urology (2020)
Our data highlight severe financial impact of COVID-19. Acknowledging financial hardship and thorough counseling of cancer patients should be part of the conversation during the pandemic. Treatment and surveillance of RCC patients might have to be adjusted to contemplate financial and medical needs.
Keyphrases
- coronavirus disease
- sars cov
- renal cell carcinoma
- end stage renal disease
- ejection fraction
- newly diagnosed
- affordable care act
- healthcare
- chronic kidney disease
- public health
- childhood cancer
- respiratory syndrome coronavirus
- prognostic factors
- peritoneal dialysis
- early onset
- smoking cessation
- big data
- deep learning
- artificial intelligence
- replacement therapy